FDA Investigator Erin D Mccaffery

Erin D Mccaffery has inspections in 5 countries as of 01 Sep 2023. Erin D Mccaffery has collaborated with a combinined 5005 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
101
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada, United Kingdom of Great Britain and Northern Ireland, Ireland
Co-Investigator(s):
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Alice S Tsao, Allen Lou, Amy L Mcintyre, Amy L Singer, Amy M Codella, Amy M Cramer, Ana S Cabrera, Anastasia I Offordile, Andrew I Carr, Andrew J Barrowcliff, Anita R Michael, Ankur C Patel, Ann L Demarco, Ann Marie Montemurro, Anna Kevilag, Anna Kwilas, Annemarie B Randow, Annemarie Bodnar, Anthony Abel, Anthony C Warchut, Arsen Karapetyan, Arulvathani P Arudchandran, Ashar P Parikh, Atul J Agrawal, Azza Talaat, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Bernice F Hirsch, Bo Chi, PhD, Brenda S Zimmer, PhD, Bryan L Mcguckin, Byungja E Marciante, Cara M Minelli, Carl A Huffman, III, Carolyn E Barney, Cary Greene, Catherine J Laufmann, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charles J Chacko, Charles R Cote, RIC, Cheryl A Clausen, Cheryl A Grandinetti, Christina N Maurino, Christine M Cerenzio, Christopher T Middendorf, Colin E Tack, Constantin Y Philopoulos, Cynthia Jim, CSO, Daniel J Grabicki, Daniel J Min, Daniel W Johnson, David H Smith, Dawn L Wydner, Dawn M Braswell, Deborah B Goffman, Deborah B Nixon, Denise M Visco, Investigator, Dennis Cantellops Paite, Dinesh Kumar, Doan T Nguyen, PharmD, Donald L Lech, Dorothy J Denes, Douglas C Kovacs, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Emest F Bizjak, Emily A Walters, Emmanuel J Ramos, Eric J Cunningham, Eric M Mueller, PharmD, Eric Rothschild, Erin D Mccaffrery, Esteban Beltran, Farhana Khan, Francis A Guidry, Frank J Marciniak, Frank Wackes, Fred Razzaghi, Frederick Razzack, Frederick Razzaghi, George J Flynn, George Pyramides, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Haitao Li, Haley H Seymour, Helen B Ricalde, Helen Verdel, Hitesh R Patel, Jacqueline Mdiaz Albertini, James C Maclaughlin, James L Finn, Janet L Bowen, Javier E Santos, Javier I Santos, Jawaid Hamid, Jay B Shah, Jean Blackstone Hill, Jean M Kelahan, Jeffrey J Ebersole, Jeffrey J, Ebersole, Jennifer D Hollstrom, Jessica L Pressley, Jing Fang, Joan A Loreng, Jogy George, Jonee J Mearns, Jose Acruz Gonzalez, Jose M Cayuela, Jose O Hernandez, Joseph F Mcginnis, RPh, Josh Renzon Ramilo, Joy R Kelna, Joy Rkozlowski Klena, Juanita P Versace, Julie D Bringger, Junho Pak, Justine Tomasso, Karen E D'orazio, Kassa Ayalew, MD, Katherine Szestypalow, Keith M Reilley, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kendra L Brooks, Kenneth V Miller, Kevin Obrien, Kevin P Foley, Kimberly L Schultz, Kinh Q Mac, Kristy A Zielny, Kshitij A Patkar, L Zam Lam, Laishan L Lam, Lakshmi Narasimhan, PhD, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, LCDR Debra Emerson, Li Li, Liatte Kreuger, PharmD, Liattle Krueger, Linda Thai, Lisa B Hall, Lisa Harlan, Lisa Mathew, Loretta Nemchik, Luis A Dasta, Manhar R Patel, Maotang Xhou, Maotang Zhou, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Margaret A Smithers, Margaret M Sands, Maria Cecilia Tami, PhD, Maria Estrella, Maria G Gutierrez Hoffman, Marjorie D Schultz, Mark E Parmon, Matthew A Spataro, Matthew B Casale, Matthew Sparato, Mayar M Mussa, Mei Chiung J Huang, Melba T Rivera, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Merril E Racke, Meyer J Slobotsky, Michael R Klapal, Michael Serrano, Michael Shanks, MS, Michele Gottshall, Michele L Obert, Michelle A Marsh, Miguel A Martinez, Milos Dokmanovic, PhD, Monika Borkowska, Mra Davism, Mra Mcculloughj, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nicholas A Violand, Niketa Patel, Nikki S Ramirez, Nimmy Mathews, Nina Yang, Niraj Mehta, Omolola A Shola Philips, Omotunde O Osunsanmi, Patricia A Cochran, Patricia H Dlugosz, Patsy J Domingo, Paul L Bellamy, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Regina T Brown, Richard H Penta, Richard Ledwidge (nmi), PhD, Richard W Thornton, Richard W Thorntton, Robert C Steyert, Robert D Tollefsen, Robert G Ruff, Robert Sharpnack, Robert W Jennings, Robin P Mathew, Rochelle K Kimmel, Rodney T Allnutt, Rose Ljean Mary, Russell J Glapion, Ruth A Williams, Sachinkumar V Patel, Saied A Asbagh, Saleem A Akhtar, Samina S Khan, Samuel T Walker, Sandra A Hughes, Sandra Kershaw, Sarah Adella Fave, Sarah E Mcmullen, Scott T Ballard, Sherri J Liu, Shirley H Isbill, Shirley J Berryman, Shirley S Wen, Sidney B Priesmeyer, Sinai Davis, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Susan O Oladeji, Susanna E Ford, Analyst, Susant Hadman, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Thomas J Arista, Tonia F Bernard, Tonya R Johnson, Tracy K Li, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Tynna N Hadley, Unnee Ranjan, Verlinda A Narcisse, Wayne E Seifert, Wayne J Meyer, Whitney S Reynolds, William Chang, William J Muszynski, William R Chang, Willy A Orantes, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Xu Michael Di, PhD, Youmin Wang, Yuesheng Ye, Yumi J Hiramine, Yun Wu, PhD, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu, Zhihao Qiu (Peter), PhD, Zhijin Chen

Erin D Mccaffery's Documents

Publish Date Document Type Title
April, 2002 FDA 483 Pfizer Inc. - Form 483, 2002-04-03
September, 2001 EIR The P.F. Laboratories Inc. - EIR, 2001-09-21
November, 2003 EIR Ivax Pharmaceuticals Inc - EIR, 2003-11-17
June, 2004 FDA 483 Response Pliva, Inc. - Form 483R, 2004-06-16
October, 2002 FDA 483 Warner Chilcott US LLC - Form 483, 2002-10-18
April, 2001 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2001-04-24
December, 2004 EIR Actavis Totowa LLC - EIR, 2004-12-01
January, 2001 FDA 483 Response Merck, Inc. - Form 483R, 2001-02-16
February, 2004 FDA 483 Response Novus Fine Chemicals - Form 483R, 2004-03-08
January, 2010 FDA 483 CorePharma, LLC - Form 483, 2010-01-20
January, 2003 EIR Actavis Elizabeth LLC - EIR, 2003-01-15
July, 2004 EIR Leading Pharma, LLC - EIR, 2004-07-21
January, 2012 EIR Actavis Elizabeth LLC - EIR, 2012-01-13
August, 2002 FDA 483 Eirchem Pharma Services Limited - Form 483, 2002-08-30
April, 2011 FDA 483 Actavis Elizabeth LLC - Form 483, 2011-04-26
September, 2004 EIR Patheon Inc. - EIR, 2004-10-15
May, 2001 FDA 483 Sharp Corporation - Form 483, 2001-05-23
November, 2003 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2003-11-19
July, 2004 FDA 483 Response Leading Pharma, LLC - Form 483R, 2004-08-09
June, 2005 FDA 483 Response CELGENE CORPORATION - Form 483R, 2005-10-14
June, 2002 EIR Sharp Corporation - EIR, 2002-06-14
March, 2010 FDA 483 CELGENE CORPORATION - Form 483, 2010-03-19
December, 2001 EIR Hoffmann La Roche Inc - EIR, 2001-12-12
January, 2001 EIR Merck, Inc. - EIR, 2001-01-19
February, 2008 FDA 483 Hoffmann La Roche Inc - Form 483, 2008-02-05
September, 2005 EIR McNeil PPC Inc. - EIR, 2005-09-29
October, 2006 FDA 483 Response Hoffmann La Roche Inc - Form 483R, 2006-11-01
September, 2000 FDA 483 Eli Lilly Co. Ltd. - Form 483, 2000-09-22
February, 2003 EIR Hoffmann La Roche Inc - EIR, 2003-02-21
December, 2004 FDA 483 Actavis Totowa LLC - Form 483, 2004-12-01
September, 2000 FDA 483 Merck and Company - Form 483, 2000-09-13
December, 2006 FDA 483 Response Central Admixture Pharm Services, Inc. - Form 483R, 2006-12-13
August, 2002 EIR Eirchem Pharma Services Limited - EIR, 2002-10-03
April, 2011 EIR Actavis Elizabeth LLC - EIR, 2011-04-26
February, 2002 FDA 483 Response McNeil PPC Inc. - Form 483R, 2002-02-25
June, 2002 FDA 483 Sharp Corporation - Form 483, 2002-06-14
May, 2008 FDA 483 Actavis Totowa LLC - Form 483, 2008-05-20
September, 2001 FDA 483 Response The P.F. Laboratories Inc. - Form 483R, 2001-09-26
December, 2003 FDA 483 Actavis Elizabeth LLC - Form 483, 2003-12-15
February, 2004 EIR Novus Fine Chemicals - EIR, 2004-02-18
June, 2002 FDA 483 Response Sharp Corporation - Form 483R, 2002-06-25
January, 2001 FDA 483 Merck & Co., Inc. - Form 483, 2001-01-19
February, 2008 EIR Hoffmann La Roche Inc - EIR, 2008-02-05
May, 2011 FDA 483 Tris Pharma Inc - Form 483, 2011-05-06
May, 2005 EIR Aphena Pharma Solutions - New Jersey, LLC - EIR, 2005-05-26
April, 2003 FDA 483 Response Merck and Company - Form 483R, 2003-05-08
July, 2012 FDA 483 BRACCO DIAGNOSTICS INC - Form 483, 2012-08-06
September, 2004 FDA 483 Patheon Inc. - Form 483, 2004-09-10
March, 2009 FDA 483 Actavis Totowa LLC - Form 483, 2009-03-31
April, 2001 FDA 483 Response Ivax Pharmaceuticals Inc - Form 483R, 2001-04-26
November, 2001 EIR Colorcon, Inc - EIR, 2001-11-02
February, 2003 FDA 483 Hoffmann La Roche Inc - Form 483, 2003-02-21
April, 2004 FDA 483 Bayer HealthCare LLC - Form 483, 2004-04-16
June, 2012 FDA 483 CorePharma, LLC - Form 483, 2012-06-11
October, 2002 EIR Warner Chilcott US LLC - EIR, 2002-10-18
July, 2008 FDA 483 McNeil PPC Inc. - Form 483, 2008-07-31
May, 2000 FDA 483 Response Pfizer Inc. - Form 483R, 2000-05-23
November, 2007 FDA 483 Contract Coating Inc. - Form 483, 2007-11-06
July, 2001 FDA 483 Response The P.F. Laboratories Inc. - Form 483R, 2001-08-02
December, 2001 FDA 483 Hoffmann La Roche Inc - Form 483, 2001-12-12
March, 2002 EIR Hoffmann La Roche Inc - EIR, 2002-03-04
June, 2005 EIR CELGENE CORPORATION - EIR, 2005-06-28
January, 2003 FDA 483 Actavis Elizabeth LLC - Form 483, 2003-01-15
January, 2005 FDA 483 Discovery Laboratories Inc. - Form 483, 2005-01-21
July, 2004 FDA 483 Leading Pharma, LLC - Form 483, 2004-07-21
February, 2007 FDA 483 Halo Pharmaceutical Inc - Form 483, 2007-02-22
June, 2005 FDA 483 CELGENE CORPORATION - Form 483, 2005-06-28
May, 2010 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2010-05-17
January, 2005 EIR Discovery Laboratories Inc. - EIR, 2005-01-21
April, 2011 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2011-06-15
January, 2012 FDA 483 Actavis Elizabeth LLC - Form 483, 2012-01-13
September, 2000 EIR Eli Lilly and Company Limited - EIR, 2000-09-22
March, 2004 EIR Health Tech Inc - EIR, 2004-03-10
August, 2002 FDA 483 Bayer HealthCare LLC - Form 483, 2002-08-02
July, 2001 EIR The P.F. Laboratories Inc. - EIR, 2001-07-06
May, 2000 FDA 483 Pfizer Inc. - Form 483, 2000-05-11
April, 2001 EIR Ivax Pharmaceuticals Inc - EIR, 2001-04-24
July, 2008 EIR McNeil PPC Inc. - EIR, 2008-07-31
May, 2000 EIR Pfizer Inc. - EIR, 2000-05-11
August, 2002 FDA 483 Response Eirchem Pharma Services Limited - Form 483R, 2002-09-12
April, 2004 EIR Bayer HealthCare LLC - EIR, 2004-04-16
April, 2003 FDA 483 Merck and Company - Form 483, 2003-04-17
September, 2005 FDA 483 Response McNeil PPC Inc. - Form 483R, 2005-10-20
April, 2002 EIR Hoffmann La Roche Inc - EIR, 2002-04-30
June, 2004 FDA 483 Pliva, Inc. - Form 483, 2004-06-02
June, 2009 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2009-06-18
October, 2009 FDA 483 Actavis Elizabeth LLC - Form 483, 2009-10-22
May, 2001 EIR Sharp Corporation - EIR, 2001-05-23
October, 2006 FDA 483 Hoffmann La Roche Inc - Form 483, 2006-10-17
February, 2002 FDA 483 McNeil PPC Inc. - Form 483, 2002-02-05
December, 2003 EIR Actavis Elizabeth LLC - EIR, 2003-12-15
June, 2004 EIR Pliva, Inc. - EIR, 2004-06-02
January, 2013 FDA 483 GE Healthcare Inc. - Form 483, 2013-01-09
April, 2003 EIR Merck and Company - EIR, 2003-04-17
December, 2004 FDA 483 Response Actavis Totowa LLC - Form 483R, 2004-12-16
September, 2000 FDA 483 Eli Lilly S.A.- Irish Branch - Form 483, 2000-09-27
February, 2004 FDA 483 Novus Fine Chemicals - Form 483, 2004-02-18
December, 2006 FDA 483 Central Admixture Pharm Services, Inc. - Form 483, 2006-12-08
February, 2002 EIR McNeil PPC Inc. - EIR, 2002-02-05
January, 2005 FDA 483 Response Discovery Laboratories Inc. - Form 483R, 2005-01-31
December, 2003 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2004-01-09
April, 2002 FDA 483 Response Pfizer Inc. - Form 483R, 2002-04-22
January, 2001 FDA 483 Merck, Inc. - Form 483, 2001-01-19
September, 2005 FDA 483 McNeil PPC Inc. - Form 483, 2005-09-29
October, 2006 EIR Hoffmann La Roche Inc - EIR, 2006-10-17
April, 2002 EIR Pfizer Inc. - EIR, 2002-04-03
March, 2004 FDA 483 Health Tech Inc - Form 483, 2004-03-10
July, 2001 FDA 483 The P.F. Laboratories Inc. - Form 483, 2001-07-06
October, 2002 FDA 483 Response Warner Chilcott US LLC - Form 483R, 2002-11-15
September, 2001 FDA 483 The P.F. Laboratories Inc. - Form 483, 2001-09-21
September, 2010 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2010-09-14
September, 2000 FDA 483 Response Eli Lilly and Company Limited - Form 483R, 2000-10-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more